439208147	439208147	CD	B-NP	O
|	|	NN	I-NP	O
AMC	AMC	NN	I-NP	O
|	|	NN	I-NP	O
68446510	68446510	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
633422	633422	CD	B-NP	O
|	|	CC	I-NP	O
2/9/1996	2/9/1996	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/28/1996	5/28/1996	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/12/1996	10/12/1996	CD	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
ATYPICAL	ATYPICAL	NN	B-NP	O
ANGINA	ANGINA	NN	I-NP	O
AND	AND	CC	B-NP	O
CORONARY	CORONARY	NN	I-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
76	76	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
anginal	anginal	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
for	for	IN	B-PP	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
month	month	NN	I-NP	O
post-PTCA	post-PTCA	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
known	know	VBN	I-VP	O
multivessel	multivessel	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
angioplasty	angioplasty	JJ	B-ADJP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
six	six	CD	B-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
rest	rest	NN	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
non-diagnostic	non-diagnostic	JJ	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
initial	initial	JJ	B-NP	O
troponin	troponin	NN	I-NP	O
and	and	CC	I-NP	O
CK	CK	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
's	's	POS	B-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
include	include	VBP	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
prior	prior	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
,	,	,	O	O
non-insulin	non-insulin	JJ	B-NP	O
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
age	age	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
sex	sex	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
April	April	NNP	B-NP	O
1995	1995	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
his	his	PRP$	B-NP	O
first	first	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
7/10/95	7/10/95	CD	B-NP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	O	O
minimal	minimal	JJ	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
initially	initially	RB	B-ADVP	O
was	be	VBD	B-VP	O
210	210	CD	B-NP	O
and	and	CC	O	O
MB	MB	NN	B-NP	B-protein
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
done	do	VBN	I-VP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	O	O
rule	rule	NN	B-NP	O
in	in	IN	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/23/95	10/23/95	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
with	with	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
right	right	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
39	39	CD	B-NP	O
and	and	CC	I-NP	O
14	14	CD	I-NP	O
,	,	,	O	O
mildly	mildly	RB	B-VP	O
elevated	elevate	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
three	three	CD	B-NP	O
vessel	vessel	NN	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
apical	apical	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
with	with	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
two	two	CD	B-NP	O
serial	serial	JJ	I-NP	O
95	95	CD	I-NP	O
%	%	NN	I-NP	O
stenoses	stenose	VBZ	B-VP	O
distally	distally	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
first	first	JJ	I-NP	O
diffuse	diffuse	JJ	I-NP	O
marginal	marginal	JJ	I-NP	O
branch	branch	NN	I-NP	O
had	have	VBD	B-VP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
diffuse	diffuse	JJ	I-NP	O
luminal	luminal	JJ	I-NP	O
irregularity	irregularity	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

Posterior	Posterior	JJ	B-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

Systolic	Systolic	JJ	B-NP	O
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
with	with	IN	B-PP	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
71	71	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/23/95	10/23/95	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
balloon	balloon	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
and	and	CC	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
11/1/95	11/1/95	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
exercise	exercise	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
went	go	VBD	B-VP	O
five	five	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
second	second	JJ	I-NP	O
stopping	stopping	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
leg	leg	NN	B-NP	O
fatigue	fatigue	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
2	2	CD	I-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
segment	segment	NN	I-NP	O
depression	depression	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
with	with	IN	B-PP	O
angioplasty	angioplasty	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
mid	mid	JJ	I-NP	O
posterior	posterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
with	with	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
residual	residual	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
dissection	dissection	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
margin	margin	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
vessel	vessel	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
,	,	,	O	O
Atenolol	Atenolol	NNP	B-NP	O
,	,	,	O	O
Micronase	Micronase	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
enoxaparin	enoxaparin	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
well	well	RB	B-ADVP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
retrosternal	retrosternal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
10/10	10/10	CD	B-NP	O
at	at	IN	B-PP	O
approximately	approximately	RB	B-NP	O
6	6	CD	I-NP	O
p.m.	p.m.	RB	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
took	take	VBD	B-VP	O
three	three	CD	B-NP	O
sublinguals	sublingual	NNS	I-NP	O
without	without	IN	B-PP	O
relief	relief	NN	B-NP	O
and	and	CC	O	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
with	with	IN	B-PP	O
5/10	5/10	CD	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
relief	relief	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
with	with	IN	B-PP	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
and	and	CC	O	O
intravenous	intravenous	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
brought	bring	VBD	B-VP	O
significant	significant	JJ	B-NP	O
relief	relief	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
non-diagnostic	non-diagnostic	JJ	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	O
for	for	IN	B-PP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
anginal	anginal	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
C4-C5	C4-C5	NN	B-NP	B-DNA
radiculopathy	radiculopathy	NN	I-NP	O
with	with	IN	B-PP	O
steroid	steroid	NN	B-NP	O
injection	injection	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
inguinal	inguinal	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
benign	benign	JJ	B-NP	O
prostatic	prostatic	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
transurethral	transurethral	JJ	I-NP	O
resection	resection	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
prostate	prostate	NN	I-NP	O
.	.	.	O	O

CURRENT	CURRENT	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Enteric	Enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
7.5	7.5	CD	I-NP	O
q.d.	q.d.	NNP	I-NP	O
,	,	,	I-NP	O
Atenolol	Atenolol	NNP	I-NP	O
75	75	CD	I-NP	O
q.d.	q.d.	NNP	I-NP	O
,	,	,	I-NP	O
Micronase	Micronase	NNP	I-NP	O
5	5	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
enoxaparin	enoxaparin	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
allergic	allergic	JJ	B-ADJP	O
to	to	TO	B-PP	O
penicillin	penicillin	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
54	54	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
114/78	114/78	CD	I-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
saturation	saturation	NN	B-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
four	four	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
100	100	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
of	of	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	O
and	and	CC	I-NP	O
Heparin	Heparin	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Benign	Benign	NNP	B-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Few	Few	JJ	B-NP	O
basilar	basilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Examination	Examination	NN	B-NP	O
showed	show	VBD	B-VP	O
bradycardia	bradycardia	NN	B-NP	O
with	with	IN	B-PP	O
II/VI	II/VI	NN	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
and	and	CC	I-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Benign	Benign	NNP	B-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	O	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
potassium	potassium	NN	I-NP	O
of	of	IN	B-PP	O
3.9	3.9	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
37.1	37.1	CD	B-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
of	of	IN	B-PP	O
0	0	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
CK	CK	NN	B-NP	B-protein
initially	initially	RB	B-ADVP	O
of	of	IN	B-PP	O
121	121	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
sinus	sinus	NN	I-NP	O
bradycardia	bradycardia	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
new	new	JJ	I-NP	O
change	change	NN	I-NP	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
old	old	JJ	B-NP	O
EKG	EKG	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Assessment	Assessment	NN	B-NP	O
was	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
basically	basically	RB	B-ADVP	O
a	a	DT	B-NP	O
76	76	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	B-ADJP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
or	or	CC	I-NP	O
CK	CK	NN	I-NP	O
values	value	NNS	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
his	his	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
recent	recent	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
and	and	CC	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
appeared	appear	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
CK	CK	NN	I-NP	O
flat	flat	JJ	I-NP	O
and	and	CC	I-NP	O
repeat	repeat	NN	I-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
0	0	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
Heparin	Heparin	NN	I-NP	O
and	and	CC	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
interval	interval	NN	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
time	time	NN	B-NP	O
until	until	IN	B-SBAR	O
he	he	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
aspirin	aspirin	NN	I-NP	O
therapy	therapy	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
81	81	CD	B-NP	O
with	with	IN	B-PP	O
simvastatin	simvastatin	NN	B-NP	O
started	start	VBD	B-VP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
received	receive	VBD	B-VP	O
repeat	repeat	NN	B-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
1/9/96	1/9/96	CD	B-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
PTA	PTA	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
posterior	posterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
PTA	PTA	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descending	NN	I-NP	O
,	,	,	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
distal	distal	JJ	B-ADJP	O
left	leave	VBD	B-VP	O
anterior	anterior	RB	I-VP	O
descending	descend	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
distal	distal	JJ	I-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
giving	give	VBG	B-VP	O
rise	rise	NN	B-NP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
PLV	PLV	NN	I-NP	O
branches	branch	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
was	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
get	get	VB	I-VP	O
a	a	DT	B-NP	O
distal	distal	JJ	I-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
PTCA	PTCA	NN	I-NP	O
tomorrow	tomorrow	NN	B-NP	O
when	when	WRB	B-ADVP	O
there	there	EX	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
surgical	surgical	JJ	B-NP	O
back-up	back-up	NN	I-NP	O
available	available	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
Heparin	Heparin	NN	I-NP	O
and	and	CC	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
overnight	overnight	RB	B-ADVP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
recurrent	recurrent	JJ	I-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/16/96	10/16/96	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
PTCA	PTCA	NN	B-NP	O
times	time	NNS	I-NP	O
three	three	CD	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
60	60	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
ballooned	balloon	VBD	B-VP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
distal	distal	JJ	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
was	be	VBD	B-VP	O
ballooned	balloon	VBN	I-VP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
residual	residual	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
distal	distal	JJ	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	NN	I-NP	O
descending	descend	VBG	B-VP	O
with	with	IN	B-PP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
ballooned	balloon	VBD	B-VP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
residual	residual	NN	I-NP	O
.	.	.	O	O

Post-PTCA	Post-PTCA	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Heparin	Heparin	NN	B-NP	O
overnight	overnight	RB	B-ADVP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
recurrent	recurrent	JJ	I-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
issue	issue	NN	I-NP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
of	of	IN	B-PP	O
whether	whether	IN	B-SBAR	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
given	give	VBN	B-VP	O
its	its	PRP$	B-NP	O
atypical	atypical	JJ	I-NP	O
nature	nature	NN	I-NP	O
was	be	VBD	B-VP	O
cardiac	cardiac	JJ	B-ADJP	O
in	in	IN	B-PP	O
etiology	etiology	NN	B-NP	O
although	although	IN	B-SBAR	O
he	he	PRP	B-NP	O
definitely	definitely	RB	B-ADVP	O
had	have	VBD	B-VP	O
disease	disease	NN	B-NP	O
on	on	IN	B-PP	O
angiography	angiography	NN	B-NP	O
but	but	CC	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
significant	significant	JJ	B-NP	O
possibility	possibility	NN	I-NP	O
for	for	IN	B-PP	O
other	other	JJ	B-NP	O
etiologies	etiology	NNS	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
source	source	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
discomfort	discomfort	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
cervical	cervical	JJ	B-NP	O
radiculopathy	radiculopathy	NN	I-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
arm	arm	NN	I-NP	O
numbness	numbness	NN	I-NP	O
and	and	CC	O	O
occasional	occasional	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
difficulty	difficulty	NN	B-NP	O
distinguishing	distinguish	VBG	B-VP	O
from	from	IN	B-PP	O
any	any	DT	B-NP	O
anginal-like	anginal-like	JJ	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
gastrointestinal	gastrointestinal	JJ	B-NP	O
distress	distress	NN	I-NP	O
with	with	IN	B-PP	O
frequent	frequent	JJ	B-NP	O
gaseousness	gaseousness	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
basically	basically	RB	I-VP	O
observed	observe	VBN	I-VP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
his	his	PRP$	B-NP	O
Heparin	Heparin	NN	I-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
enoxaparin	enoxaparin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Captopril	Captopril	NNP	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
simvastatin	simvastatin	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
recurrent	recurrent	JJ	I-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
interim	interim	JJ	I-NP	O
observation	observation	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
out-patient	out-patient	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Additional	Additional	JJ	B-NP	O
in-house	in-house	JJ	I-NP	O
issues	issue	NNS	I-NP	O
included	include	VBD	B-VP	O
that	that	IN	B-SBAR	O
gastrointestinally	gastrointestinally	RB	B-ADVP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Prilosec	Prilosec	NNP	B-NP	O
and	and	CC	I-NP	O
Maalox	Maalox	NNP	I-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
gaseousness	gaseousness	NN	I-NP	O
and	and	CC	I-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
crackles	crackle	NNS	I-NP	O
on	on	IN	B-PP	O
examination	examination	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
required	require	VBD	B-VP	O
some	some	DT	B-NP	O
O2	O2	NN	I-NP	O
supplementation	supplementation	NN	I-NP	O
initially	initially	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
presented	present	VBD	B-VP	O
but	but	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
O2	O2	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

As	As	RB	B-ADVP	O
far	far	RB	I-ADVP	O
as	as	IN	B-SBAR	O
his	his	PRP$	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
out-patient	out-patient	JJ	I-NP	B-protein
Micronase	Micronase	NN	I-NP	I-protein
with	with	IN	B-PP	O
b.i.d.	b.i.d.	NN	B-NP	O
fingerstick	fingerstick	NN	I-NP	O
monitoring	monitoring	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	O	O
electrolyte	electrolyte	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nutrition	nutrition	NN	B-NP	O
wise	wise	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
and	and	CC	I-NP	O
magnesium	magnesium	NN	I-NP	O
were	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
optimally	optimally	RB	B-VP	O
repleted	replete	VBN	I-VP	O
given	give	VBN	I-VP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Enteric	Enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Atenolol	Atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Micronase	Micronase	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rater	Rater	NNP	I-NP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
follow-up	follow-up	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
was	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
would	would	MD	B-VP	O
call	call	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Hedges	Hedges	NNP	I-NP	O
for	for	IN	B-PP	O
follow-up	follow-up	NN	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
SAMUAL	SAMUAL	NNP	B-NP	O
C.	C.	NNP	I-NP	O
DUCH	DUCH	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SL26	SL26	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ORLANDO	ORLANDO	NNP	B-NP	O
J.	J.	NNP	I-NP	O
SOSBY	SOSBY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
JZ2	JZ2	NNP	I-NP	O
CZ901/3039	CZ901/3039	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
31556	31556	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

EKHJI08N3H	EKHJI08N3H	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
10/25/96	10/25/96	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/6/96	7/6/96	CD	B-NP	O

